India's Biocon has expanded its pipeline of biosimilars with a $3.3 billion deal to acquire a portfolio of drugs from Viatris, the parent of its longstanding partner Mylan, which will boost its ...
Hosted on MSN11mon
Biocon leads India's push into blockbuster weight-loss drugs as patents for Saxenda, Wegovy and Ozempic set to expireaccording to a March 27 statement by Biocon. Indian drugmakers Sun Pharmaceutical Industries, Dr. Reddy’s Laboratories, and Cipla are also developing their anti-obesity drugs. Novo Nordisk ...
two Microbiological Control Laboratories, and two Warehouses. Recent media reports indicate that Bank of America Securities ...
Biocon’s subsidiary Biocon Pharma has received the Food and Drug Administration’s permission for norepinephrine bitartrate injection (4 mg/4 ml, 1 mg/ml) in a single-dose vial, the company ...
BRIDGEWATER, N.J., and BENGALURU, India, March 7, 2025 /PRNewswire/ -- Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE code ...
Who are peers of Biocon Ltd? The peers of Biocon Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Mankind Pharma Ltd, Dr Reddys ...
a subsidiary of Biocon Limited, is a unique, fully integrated, global biosimilars company committed to transforming healthcare and transforming lives. It is capitalizing on its 'lab to market ...
Biocon Biologics Ltd, a fully integrated global biosimilars company and a subsidiary of Biocon, has announced a collaboration with Civica, Inc. Under this agreement, Biocon Biologics will supply ...
Biocon Pharma Limited, a wholly owned subsidiary of Biocon Limited, has received U.S. Food and Drug Administration (FDA) approval for its Abbreviated New Drug Application (ANDA) for Norepinephrine ...
Biocon Academy, a ‘Centre of Excellence for Advanced Learning ... Lupin, Merck, Baxter, Dr. Reddy's Laboratories, and Emcure among others. Eight outstanding students, who topped their respective ...
BENGALURU: Biocon Foundation, the Corporate Social Responsibility (CSR) arm of Biocon Group marked two decades of commitment to social impact and community development. To commemorate this ...
Syngene International Limited has announced a strategic investment in O2 Renewable Energy II Private Limited, marking a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback